Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Ultrasound-guided quadratus lumboum block versus transversus abdominis plane block for post-operative analgesia in patients undergoing total abdominal hysterectomy: A systematic review and meta-analysis.

European journal of obstetrics & gynecology and reproductive biology: X·2026
Same author

Analytical evaluation of the impact of formaldehyde exposure on general health and sleep quality: the moderating role of physical activity.

International archives of occupational and environmental health·2025
Same author

Deciphering Persistent D-Dimer Elevation in Paraquat Poisoning: A Mortality Assessment Case Study.

Clinical case reports·2025
Same author

An evaluation of photobiomodulation effects on human gingival fibroblast cells under hyperglycemic condition: an in vitro study.

Lasers in medical science·2023
Same author

Robotized polarization characterization platform for free-space quantum communication optics.

The Review of scientific instruments·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

Desarrollo de Fármacos

Kimia Mohammadi1

  • 1Kimiagar Toos Pharmaceutical Company, Mashhad, Khorasan Razavi, Iran (Islamic Republic of).

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Este estudio desarrolló inhibidores selectivos de ROCK 2 para el tratamiento de la enfermedad de Alzheimer. El compuesto más selectivo inhibió 19 quinasas, mostrando potencial para reducir efectos secundarios.

Palabras clave:
Enfermedad de AlzheimerInhibidores de quinasasDesarrollo de fármacosROCK 2Quinasas

Más Videos Relacionados

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Área de la Ciencia:

  • Bioquímica
  • Farmacología
  • Neurociencia

Sus antecedentes:

  • Las rho-quinasas (ROCKs) son cruciales para los procesos celulares y están implicadas en enfermedades neurodegenerativas.
  • La señalización de ROCK exacerba la progresión de la enfermedad de Alzheimer (EA).
  • La inhibición de ROCK 2 ofrece potencial terapéutico para la EA al mejorar la autofagia y reducir la neuroinflamación.

Objetivo del estudio:

  • Diseñar e identificar inhibidores selectivos de ROCK 2 para el tratamiento potencial de la enfermedad de Alzheimer.
  • Abordar el desafío de la similitud estructural entre ROCK 1 y ROCK 2 para una inhibición selectiva.
  • Minimizar los efectos secundarios fuera del objetivo mediante el cribado de selectividad de quinasas.

Principales métodos:

  • Se diseñaron 63 compuestos inspirados en inhibidores conocidos de ROCK2 y grupos funcionales.
  • Se utilizó cribado virtual (acoplamiento molecular) contra 23 estructuras de proteínas quinasas del PDB.
  • Se evaluó la selectividad del inhibidor basándose en las puntuaciones de acoplamiento y las constantes de inhibición (relaciones Ki > 10).

Principales resultados:

  • 17 compuestos exhibieron selectividad variable para ROCK 2 sobre otras quinasas.
  • El compuesto 'Peic' demostró alta selectividad, con Ki > 10 para 19 quinasas.
  • El compuesto 'Si' mostró la menor selectividad, con Ki > 10 para solo 4 quinasas.

Conclusiones:

  • Los 17 compuestos principales mostraron una potencia y selectividad prometedoras en 4 a 19 quinasas.
  • Estos inhibidores selectivos de ROCK 2 son candidatos potenciales para la terapia de la enfermedad de Alzheimer.
  • Los compuestos desarrollados pueden reducir los síntomas de la EA con menos efectos adversos debido a la selectividad.